CLOV (Clover Health Investments) Piotroski F-Score: 4 (As of Jun. 24, 2026) — Near Median


CLOV Clover Health Investments Corp CLOV
81 GF Score
Price $5.21
GF Value $3.95
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Clover Health Investments Piotroski F-Score?

Clover Health Investments CLOV +3.17% 81 Piotroski F-Score is 4 as of Jun. 24, 2026, which is at its 10-year median of 4.00. GuruFocus rates CLOV with a GF Score™ of 81/100 and a GF Value™ of $3.95 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 18 Healthcare Plans companies, Clover Health Investments ranks worse than 83.33% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Clover Health Investments has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Clover Health Investments's Piotroski F-Score or its related term are showing as below:

CLOV' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 4   Max: 6
Current: 4

During the past 7 years, the highest Piotroski F-Score of Clover Health Investments was 6. The lowest was 3. And the median was 4.

Clover Health Investments  (NAS:CLOV) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Clover Health Investments Piotroski F-Score Related Terms


Clover Health Investments Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Clover Health Investments's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clover Health Investments Piotroski F-Score Chart

Clover Health Investments Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial 4.00 4.00 6.00 6.00 3.00

Clover Health Investments Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 4.00 3.00 3.00 4.00

CLOV vs PGNY, ALHC, PFHO: Piotroski F-Score Comparison

For the Healthcare Plans subindustry, Clover Health Investments's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clover Health Investments Piotroski F-Score vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Clover Health Investments's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Clover Health Investments's Piotroski F-Score falls into.


CLOV
81GF Score
Clover Health Investments Corp CLOV
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -10.578 + -24.377 + -49.32 + 27.334 = $-57 Mil.
Cash Flow from Operations was 5.408 + 12.103 + -68.152 + 107.895 = $57 Mil.
Revenue was 477.62 + 496.65 + 487.707 + 749.189 = $2,211 Mil.
Gross Profit was 99.628 + 73.177 + 74.208 + 159.541 = $407 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(583.717 + 574.987 + 559.659 + 541.011 + 697.728) / 5 = $591.4204 Mil.
Total Assets at the begining of this year (Mar25) was $584 Mil.
Long-Term Debt & Capital Lease Obligation was $0 Mil.
Total Current Assets was $448 Mil.
Total Current Liabilities was $337 Mil.
Net Income was 7.408 + -9.155 + -22.092 + -1.274 = $-25 Mil.

Revenue was 356.26 + 330.986 + 336.963 + 462.331 = $1,487 Mil.
Gross Profit was 107.913 + 81.212 + 93.919 + 108.889 = $392 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(671.77 + 674.21 + 653.013 + 580.742 + 583.717) / 5 = $632.6904 Mil.
Total Assets at the begining of last year (Mar24) was $672 Mil.
Long-Term Debt & Capital Lease Obligation was $0 Mil.
Total Current Assets was $331 Mil.
Total Current Liabilities was $216 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Clover Health Investments's current Net Income (TTM) was -57. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Clover Health Investments's current Cash Flow from Operations (TTM) was 57. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-56.941/583.717
=-0.09754898

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-25.113/671.77
=-0.03738333

Clover Health Investments's return on assets of this year was -0.09754898. Clover Health Investments's return on assets of last year was -0.03738333. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Clover Health Investments's current Net Income (TTM) was -57. Clover Health Investments's current Cash Flow from Operations (TTM) was 57. ==> 57 > -57 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=0/591.4204
=0

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=0/632.6904
=0

Clover Health Investments's gearing of this year was 0. Clover Health Investments's gearing of last year was 0. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=448.021/336.583
=1.33108624

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=331.409/215.653
=1.53676972

Clover Health Investments's current ratio of this year was 1.33108624. Clover Health Investments's current ratio of last year was 1.53676972. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Clover Health Investments's number of shares in issue this year was 532.501. Clover Health Investments's number of shares in issue last year was 497.056. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=406.554/2211.166
=0.18386408

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=391.933/1486.54
=0.26365453

Clover Health Investments's gross margin of this year was 0.18386408. Clover Health Investments's gross margin of last year was 0.26365453. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=2211.166/583.717
=3.78807881

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=1486.54/671.77
=2.21287048

Clover Health Investments's asset turnover of this year was 3.78807881. Clover Health Investments's asset turnover of last year was 2.21287048. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+1+0+0+0+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Clover Health Investments has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 4 mean?
Clover Health Investments (CLOV) has a Piotroski F-Score of 4 as of Jun. 24, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Clover Health Investments and its competitors. This is near median its historical median of 4.00. Over the past decade, Clover Health Investments' Piotroski F-Score has ranged from 3.00 to 6.00. According to the industry distribution chart, Clover Health Investments ranks #15 out of 18 companies in the Healthcare Plans industry, placing it in the top 83.3%.
Is Clover Health Investments' Piotroski F-Score too high?
Clover Health Investments' current Piotroski F-Score of 4 is near median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 6.00. The Healthcare Plans industry median Piotroski F-Score is 6.00. Clover Health Investments' value of 4 is 33.3% below this industry median. Based on the distribution chart, Clover Health Investments ranks #15 out of 18 companies in the Healthcare Plans industry, which is in the bottom quartile relative to peers. Overall, Clover Health Investments has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clover Health Investments' Piotroski F-Score compare to PGNY and ALHC?
According to the Healthcare Plans industry distribution chart, Clover Health Investments ranks #15 out of 18 companies for Piotroski F-Score. This places Clover Health Investments in the lower half of its industry. The industry median Piotroski F-Score is 6.00. Clover Health Investments' value of 4 is 33.3% below this benchmark. Historically, Clover Health Investments' own Piotroski F-Score has ranged from 3.00 to 6.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 6.00, Clover Health Investments has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Plans company?
The median Piotroski F-Score among Healthcare Plans companies is 6.00, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clover Health Investments's current Piotroski F-Score of 4 is 33.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Clover Health Investments and its competitors. For the Healthcare Plans industry, the median Piotroski F-Score is 6.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clover Health Investments's current Piotroski F-Score is 4, which is near median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clover Health Investments stock overvalued right now?
Based on GuruFocus' analysis, Clover Health Investments (CLOV) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.95, compared to a current price of $5.21 — trading 31.9% above its estimated fair value. The current Piotroski F-Score is 4, which is near median its 10-year median of 4.00 and 33.3% below the Healthcare Plans industry median of 6.00. Clover Health Investments' overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Clover Health Investments (CLOV), the current Piotroski F-Score is 4 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clover Health Investments (CLOV) Overvalued in 2026?

Based on GuruFocus' analysis, Clover Health Investments stock appears to be overvalued. The current stock price of $5.21 is trading 31.9% above its estimated GF Value™ of $3.95. GuruFocus considers Clover Health Investments to be Significantly Overvalued.

Key valuation signals for CLOV:

  • Piotroski F-Score: 4 (near median its 10-year median of 4.00)
  • GF Value™: $3.95 vs. price of $5.21 (31.9% above fair value)
  • GF Score™: 81/100 with 5 warning signs
  • Industry Position: 33.3% below the Healthcare Plans median (#15 of 18)

No single metric tells the full story. See the CLOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clover Health Investments Business Description

Other Exchanges 7QD:GermanyCLOV34:Brazil
Address 3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
81GF Score

Get the complete analysis for CLOV

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.21
Price
$3.95
GF Value